See other companies on Welcome to the Jungle
RubiconMD
eConsult specialist expertise platform
- 101-200 employees
- Healthcare
- B2B
- SaaS
- MedTech
- Midtown South, New York, NY
Jump to section
Company mission
To democratize medical expertise through virtual-first specialty care solutions.
20% employee growth in 12 months
Our take
In an ideal world, every patient would have access to the specialist care they need. RubiconMD takes a significant step towards this goal with an eConsult platform that connects primary care clinicians to top specialists.
It enables clinicians to consult specialists in treating complex problems, ranging from heart conditions to mental health issues. This communication allows these professionals to share insights remotely, which can result in fewer unnecessary referrals and reduced patient waiting times.
The company continues to grow with new funding, but it is far from the only player in this space. It will have to stay on top of its game if its to continue to compete with larger and better-established competitors such as ReferralMD, as well as similar startups like AristaMD.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- We pay 100% of a base plan for full-time employees and fund 40% of premiums for medical coverage for dependents or domestic partners
- Company-wide weekly updates with leadership, Lunch & Learns, and more
- All Summer Fridays are half days
- Mental Health Days
- We are a remote-culture first, NYC-based office second
- Eden Health
- 401k with Match
- Flexible to your desired schedule
- Unlimited PTO
- In-person quarterly meetings
- Unlimited access to Bravely, professional confidential coaching service
- Mentorship and manager training sessions led by internal and external
- 100% fully paid for 12 weeks off to care for your family
- Development budget
Company values
- Human - We bring our full selves to work and embrace individuals' diversity and values
- Agile - We seek and value each and every individual’s opinion for improvements
- Innovative - We constantly experiment with new ideas and possibilities
- Collaborative - We achieve our goals by listening and making ourselves accessible to each other
Funding (last 2 of 6 rounds)
Mar 2020
$18m
SERIES C
Apr 2018
$13.8m
SERIES B
Total funding: $37.9m
This company has top investors
Leadership
Gil Addo
(CEO)After graduating Harvard Business School, they became a Business Development Director at Targeted Cell Therapies. Then became a Consultant at Putnam Associates focused exclusively on pharma/biotech sector and left this role to co-found RubiconMD.
Carlos Reines
(President)They joined Telefonica S.A in 2009, first as Global CTO- Network Planning and then as Global CTO- Head of Transformation Projects. On leaving this role, they co-founded RubiconMD and also continues to be a Young Global Leader at the World Economic Forum.